95
Participants
Start Date
December 31, 2001
Study Completion Date
February 28, 2007
Cerezyme
Cerezyme doses of 20-60U/kg every 2 weeks (Q2 Arm) or 40-120 U/kg every 4 weeks (Q4 Arm).
New York University, New York
Mt. Sinai Medical Center, New York
New York Oncology/Hematology PC, Latham
Hemophilia Center of Western New York, Buffalo
University of Pittsburgh, Pittsburgh
Children's Hospital of Philadelphia, Philadelphia
Children's National Medical Center, Washington D.C.
Estadual de Hematologia Arthur de Siqueira Cavalcanti (HEMORIO), Rio de Janeiro
Duke University Medical Center, Durham
Emory University, Atlanta
University Research Foundation for Lysosomal Storage Disease, Inc., Coral Springs
Istituto per l'Infanzia Burlo-Garofolo, Trieste
Children's Hospital Research Foundation, Cincinnati
Midwest Cancer Research Group, Inc., Skokie
Children's Memorial Hospital, Chicago
"Universita degli Studi di Napoli Federico II", Naples
University of Utah, Salt Lake City
Oregon Health & Science University, Portland
Massachusetts General Hospital, Boston
Institute for Genetics Medicine Saint Peter's University Hospital, New Brunswick
Holy Name Hospital, Teaneck
Mount Sinai Hospital, Toronto
Istituto Giannina Gaslini, Genova
Instytut Pomnik Centrum Zdrowia Dzeicka, Warsaw
Hospital Vall d´Hebrón, Barcelona
Royal Free Hospital, London
Genzyme, a Sanofi Company
INDUSTRY